Abilify, Aripiprazola News

Investors must wait until probably next year to find out exactly what the withdrawal of Abilify's European marketing application means for Targacept Inc.'s chances overseas with lead asset TC-5214 in adjunctive depression therapy.

Nov. 30, 2009 -- The drug Abilify may help ease the symptoms of irritability related to autism in children and adolescents.

When five defendants are brought before a New York federal judge to face charges for the terror attacks of Sept.

Schizophrenia The European Medicines Agency has been formally notified by Otsuka Pharmaceutical Europe Ltd of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Abilify tablets, orodispersible tablets and oral solution.

The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co.

Children and teens who took antipsychotic medicines in a study gained weight and developed increased blood-fat levels, possibly harming their future health, researchers in New York State said.

A study has shown that four antipsychotic drugs cause weight gain in youth that were taking them.

Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said on Tuesday.

Children on widely used psychiatric drugs can quickly gain an alarming amount of weight; many pack on nearly 20 pounds and become obese within just 11 weeks, a study found.

Drugmaker Bristol-Myers Squibb Co. on Thursday reported a solid increase in third-quarter revenue, due to strong sales growth for its blockbuster blood thinner Plavix and other key medicines, and boosted its profit forecast.

Bristol-Myers Squibb Co., the world's No. 15 drug maker by revenue, reports earnings for the third quarter on Thursday morning.

In July of 2007, comedian Michael Showalter was at a bar in Park Slope doing stand-up about an unwitting experience he'd had with a prescription drug called Seroquel.

Bristol-Myers Squibb Co. cut the sales force for its second best-selling drug, the antipsychotic Abilify, six months after extending its contract to market the product with Tokyo-based Otsuka Pharmaceutical Co.

Where is the proof that SCHIZOPHRENIA is a lifelong disease? And according to http://www.cchrint.org/psychdrugdangers/, Abilify ALONE has been directly linked to 103 deaths, 98 completed suicides, and many other adverse effects.

ABILIFY now available in Canada with several benefits: efficacy, good safety, tolerability and neutral impact on weight, cholesterol and blood sugar levels A new treatment option for Canadians with schizophrenia , ABILIFY , is now available in Canada.

Schering-Plough Corp.'s new drug for schizophrenia and bipolar disorder, Saphris, has been approved by the Food and Drug Administration, the company said Friday.

The seventh in an important series of Consumer Reports drug AdWatch videos is now available online.

Abilify is the brand name of the drug aripiprazole, an antipsychotic medication approved by the FDA in 2002.

Abilify, also known by its generic medication name of Aripiprazole, has received approval from the FDA for use in schizophrenia and in bipolar disorder.

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the patient share of Bristol-Myers Squibb/Otsuka's Abilify has grown in the first three lines of therapy since the 2008 analysis of prescribing trends in newly diagnosed schizophrenia patients.